UBAP2L and nonpapillary renal cell carcinoma: Herein, we constructed the acquired sunitinib-resistant ccRCC PDX model and cell models and demonstrated that UBAP2L regulates sunitinib resistance in renal cell carcinoma by modulating stress granule assembly.